Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- EPS Establishes Subsidiary to Support Clin. Trials in Asia
April 17, 2006
- Seretide Lowers Mortality of COPD: GSK
April 17, 2006
- R&D NEWS IN BRIEF
April 17, 2006
- Pharmacists Want More Info. on Changes in Packaging, Formulation
April 17, 2006
- Sankyo Daiichi Aims for \100 Bil. Sales in CHC Business with Acquisition of Zepharma
April 17, 2006
- Boehringer Ingelheim to Remain Independent: Dr Banchi
April 17, 2006
- Major Drug Firms Offer Better Child-Rearing Leave than Law Requires
April 17, 2006
- REGULATORY NEWS IN BRIEF
April 10, 2006
- Daiichi Sankyo Selects 5 Top-Priority Projects
April 10, 2006
- Ono, Medarex in Collaboration to Develop Antibody Therapeutics
April 10, 2006
- R&D NEWS IN BRIEF
April 10, 2006
- NEW BOOK
April 10, 2006
- SEMINAR
April 10, 2006
- Growing Need for Generics with High Added Value: Prof. Ueno
April 10, 2006
- Daiichi Sankyo Acquires Zepharma
April 10, 2006
- Astellas, Toyama Ink Licensing Agreement on New Quinolone T-3811
April 10, 2006
- Market for Bio-derived Materials to Grow 54% by 2010: Fuji-Keizai
April 10, 2006
- Astellas Switches to Disease-Based 2-Line Marketing System
April 10, 2006
- SELF-MEDICATION NEWS IN BRIEF
April 10, 2006
- Deloitte Touche Tohmatsu Forms "Pharma Team" to Support Life Science Industry
April 10, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…